Abstract
Endogenous growth factors and cytokines are known to have a major influence on the progression, motility and invasiveness of tumor cells. We have reported previously that conditioned media from mouse fibroblasts increases the motility of breast cancer cells. Further, we determined that keratinocyte growth factor (KGF) was an active factor from mouse fibroblasts responsible for most of the motility response in breast cancer cells. The present study examined the effect of human KGF on the motility of estrogen receptor (ER)-positive and ER-negative human breast cancer cell lines in culture using time-lapse videomicroscopy to quantify cell motility. In the present study we observed that recombinant human KGF enhanced several parameters of cellular motility in ER-positive cells but not in ER-negative cell lines. Further, we observed that the level of KGF receptor (KGFR) expression in ER-positive cells was much greater than in the ER-negative cell lines. The motility response to KGF was found to be both dose-and time-dependent. Of the three ER-positive breast cancer cell lines tested, MCF-7 cells were the most responsive to KGF stimulation. Finally, MCF-7 cells grown in estrogen-depleted media did not respond to KGF. These results suggest that KGF from stromal tissue surrounding a primary tumor mass can enhance tumor cell motility and may be an early signal in the progression of breast cancer cells to a more motile and metastatic phenotype. Thus, KGF, KGFR and/or the KGF signaling pathway may be important therapeutic targets for the treatment or prevention of breast cancer metastasis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Partin AW, Isaacs JT, Treiger B et al. Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene. Cancer Res 1989; 48: 6050–3.
Hiscox S, Hallett MB, Puntis MCA et al. Inhibition of cancer cell motility and invasion by interleukin-12. Clin Exp Metastasis 1995; 13: 396–404.
Watanabe H, Shinozaki T, Raz A et al. Expression of autocrine motility factor receptor in serum-and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis. Int J Cancer 1993; 53: 689–95.
Peehl DM, Rubin JS. Keratinocyte growth factor: an androgenregulated mediator of stromal epithelial interactions in the prostate. World J Urol 1995; 13: 312–7.
Matsumoto K, Date K, Ohmichi H et al. Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactions. Cancer Chemo Pharmacol 1996; 38: 42–7.
Rubin JS, Bottaro DP, Chedid M et al. Keratinocyte growth factor as a cytokine that mediates mesenchymal-epithelial interaction. In Goldberg ID, Rosen EM (eds): Epithelial-Mesenchymal Interactions in Cancer. Basel: Birkhäuser Verlag 1995; 191–14.
Rubin JS, Osada H, Finch PW et al. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 1989; 86: 802–6.
Baird A, Klagsbrun M. The fibroblast growth factor family; Nomenclature meeting report and recommendations. Ann NY Acad Sci 1991; 638: 13–6.
Bottaro DP, Rubin JS, Ron D et al. Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J Biol Chem 1990; 265: 12767–70.
Aaronson SA, Bottaro DP, Miki T et al. Keratinocyte growth factor. A fibroblast growth factor family member with unusual target cell specificity. Ann NY Acad Sci 1991; 638: 62–77.
Miki T, Fleming TP, Bottaro DP et al. Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 1991; 251: 72–5.
Mason IJ, Fuller-Pace F, Smith R et al. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalization and epithelial-mesenchymal interactions. Mech Dev 1994; 45: 15–30.
Ulich TR, Yi ES, Cardiff R et al. Keratinocyte growth factor is a growth factor for mammary epithelium in vivo. The mammary epithelium of lactating rats is resistant to the proliferative action of keratinocyte growth factor. Am J Pathol 1994; 144: 862–8.
Kitsberg DI, Leder P. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Oncogene 1996; 13: 2507–15.
Koos RD, Banks PK, Inkster SE et al. Detection of aromatase and keratinocyte growth factor expression in breast tumors using reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol 1993; 45: 217–25.
Bansal GS, Cox HC, Marsh S et al. Expression of keratinocyte growth factor and its receptor in human breast cancer. J Br Cancer 1997; 75: 1567–74.
Aznavoorian S, Murphy AN, Stetler-Stevenson WG et al. Molecular Aspects of Tumor Cell Invasion and Metastasis. Cancer 1993; 71: 1368–83.
Rajah, TT, Rambo DJ, Dmytryk JJ et al. Influence of antiestrogens on 3T3-fibroblast-induced motility of breast cancer cells. Chemotherapy 2001; 47: 56–69.
Jain PT, Rajah TT, Pento JT. Antitumor activity of a novel antiestrogen (Analog II) on human breast cancer cells. Anti-Cancer Drugs 1997; 8: 964–73.
Mathew AC, Rajah TT, Hurt GM et al. Influence of antiestrogens on the migration of breast cancer cells using an in vitro wound model. Clin Exp Metastasis 1997; 15: 393–9.
Rajah TT, Abidi SMA, Rambo DJ et al. The motile behavior of human breast cancer cells characterized by time-lapse videomicroscopy. In Vitro Cell Develop Biol 1998; 34: 626–8.
Van Larebeke NAF, Bracke ME, Mareel MM. Simple method of quantification of fast plasma membrane movements. Cytometry 1992; 13: 1–8.
Ropiquet F, Huguenin S, Villette JM et al. FGF7/KGF triggers cell transformation and invasion of immortalized human prostatic epithelial PNT1A cells. Int J Cancer 1999; 82: 237–43.
Cheng TPO. Minipodia, novel structures for extension of the lamella: A high-spatial-resolution video microscopic study. Exp Cell Res 1992; 203: 25–31.
Van Larebeke NAF, Bracke ME, Mareel MM. Invasive epithelial cells show more fast plasma membrane movements than related or parental non-invasive cells. Cytometry 1992; 13: 9–14.
Freiss G, Puech C, Vignon F. Extinction of insulin-like growth factor-1-mitogenic signaling by antiestrogen-stimulated fas-asociated protein tyrosine phosphatase-1 in human breast cancer cells. Mol Endocrinol 1998; 12: 568–79.
Vignon F, Bouton MM, Rochefort H. Antiestrogens inhibit the motogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Comm 1987; 164: 1502–8.
Bunone G, Briand PA, Miksicek RJ et al. Activation of the unligated estrogen receptor by EGF involves MAP kinase pathway and direct phosphorylation. EMBO J 1996; 15: 2174–83.
Curtis SW, Washbun TF, Sewall C et al. Physilolgical coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to EGF. Proc Natl Acad Sci USA 1996; 93: 12626–30.
Zhang Y, Kulp SK, Sugimoto Y et al. Keratinocyte growth factor induces aromatase activity in cultured MCF-7 human breast cancer cells. Anticancer Res 1998; 18: 2541–6.
Zang, XP Learner ML, Brackett DJ et al. KGF-induced gene expression in MCF-7 cells using cDNA expression arrays. Breast Cancer Res Treat 2000; 64: 110.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zang, X.P., Pento, J.T. Keratinocyte growth factor-induced motility of breast cancer cells. Clin Exp Metastasis 18, 573–580 (2000). https://doi.org/10.1023/A:1011997317994
Issue Date:
DOI: https://doi.org/10.1023/A:1011997317994